Metsera, Maze land on NASDAQ as IPO queue grows

A pair of IPOs that priced overnight Thursday led a growing queue of companies seeking to go public, while a liver fibrosis readout this week drove a pair of follow-ons totaling more than $650 million.

The offerings are a positive signal amid continued uncertainty in the public markets, as some investors have believed the market for IPOs won’t gain momentum until the year’s second half. And although one biotech traded flat during Friday’s session, the other was received warmly...